Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.855 USD | -10.35% | -22.92% | +3.88% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.88% | 489M | |
-1.97% | 104B | |
+2.03% | 97.42B | |
+0.79% | 22.2B | |
-17.73% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-16.02% | 15.06B | |
+3.68% | 13.98B | |
+35.09% | 11.66B |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.
- Fate Therapeutics : Reports 'Positive' Interim Trial Results for FT596, FT516 Cell Therapies in Lymphoma Patients